These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4419423)

  • 1. Proceedings: Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia.
    Wise CD; Stein L
    Psychopharmacol Bull; 1974 Jul; 10(3):48-9. PubMed ID: 4419423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stein and Wise's neurochemical model of schizophrenia].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(1):127-34. PubMed ID: 842218
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia.
    Wise CD; Baden MM; Stein L
    J Psychiatr Res; 1974; 11():185-98. PubMed ID: 4461790
    [No Abstract]   [Full Text] [Related]  

  • 4. The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls.
    Cross AJ; Crow TJ; Killpack WS; Longden A; Owen F; Riley GJ
    Psychopharmacology (Berl); 1978 Oct; 59(2):117-21. PubMed ID: 103111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine reward pathways: role of self-stimulation, memory consolidation, and schizophrenia.
    Stein L
    Nebr Symp Motiv; 1975; 22():113-59. PubMed ID: 1688
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension, a biomedical genetic approach.
    Weinshilboum R
    Prog Clin Biol Res; 1979; 32():157-81. PubMed ID: 392526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by endogenous 6-hydroxydopamine.
    Stein L; Wise CD
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():298-314. PubMed ID: 5071537
    [No Abstract]   [Full Text] [Related]  

  • 9. The dopamine hypothesis: an overview of studies with schizophrenic patients.
    Haracz JL
    Schizophr Bull; 1982; 8(3):438-69. PubMed ID: 6127808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of prolonged vasopressin administration on the level and metabolism of catecholamines in the rat brain and kidneys.
    Szmigielska H
    Acta Physiol Pol; 1976; 27(3):259-64. PubMed ID: 7918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 13. beta-Hydroxylation as a possible detoxification mechanism: role in schizophrenia.
    Evans BD; Vogel WH
    Biol Psychiatry; 1977 Aug; 12(4):583-7. PubMed ID: 889987
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.
    Lewandowski KE
    Harv Rev Psychiatry; 2007; 15(5):233-44. PubMed ID: 17924258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase deficits in the brains of schizophrenic patients.
    Wise CD; Stein L
    Science; 1973 Jul; 181(4097):344-7. PubMed ID: 4719906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the autistic syndromes.
    Coleman M
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():265-75. PubMed ID: 419334
    [No Abstract]   [Full Text] [Related]  

  • 17. Cultured human keratinocytes as a model for studying the dopamine metabolism in schizophrenia.
    Ramchand CN; Clark AE; Ramchand R; Hemmings GP
    Med Hypotheses; 1995 Jan; 44(1):53-7. PubMed ID: 7776903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients.
    Wyatt RJ; Schwartz MA; Erdelyi E; Barchas JD
    Science; 1975 Jan; 187(4174):368-70. PubMed ID: 1111112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical studies in schizophrenia.
    Thakar J
    Psychiatr J Univ Ott; 1983 Jun; 8(2):44-50. PubMed ID: 6137016
    [No Abstract]   [Full Text] [Related]  

  • 20. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.
    Illi A; Mattila KM; Kampman O; Anttila S; Roivas M; Lehtimäki T; Leinonen E
    J Clin Psychopharmacol; 2003 Oct; 23(5):429-34. PubMed ID: 14520117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.